https://www.selleckchem.com/pr....oducts/CI-1040-(PD18
Further studies of PARP inhibitors alone and in combination in this patient population are warranted. These results indicate preliminary activity of PARP inhibition in patients with IDH1/2-mutant chondrosarcoma and pulmonary epithelioid hemangioendothelioma. Further studies of PARP inhibitors alone and in combination in this patient population are warranted. Clinical utility of up-front multigene panel testing (MGPT) is directly related to the frequency of pathogenic variants (PVs) in the population screened and how genetic f
Like
Comment
Share
